← Back to Screener
Merit Medical Systems Inc (MMSI)
Price$69.79
Favorite Metrics
Price vs S&P 500 (26W)-19.03%
Price vs S&P 500 (4W)-5.70%
Market Capitalization$4.22B
P/E Ratio (Annual)32.83x
All Metrics
P/CF (Annual)14.19x
Book Value / Share (Quarterly)$26.66
P/TBV (Annual)4.99x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)9.61%
Cash Flow / Share (Quarterly)$3.58
Price vs S&P 500 (YTD)-24.75%
Gross Margin (TTM)48.70%
Net Profit Margin (TTM)8.48%
EPS (TTM)$2.13
10-Day Avg Trading Volume0.54M
EPS Excl Extra (TTM)$2.13
Revenue Growth (5Y)9.48%
EPS (Annual)$2.13
ROI (Annual)5.54%
Gross Margin (Annual)48.70%
Net Profit Margin (5Y Avg)7.17%
Cash / Share (Quarterly)$7.51
P/E Basic Excl Extra (TTM)32.83x
Revenue Growth QoQ (YoY)10.92%
EPS Growth (5Y)83.33%
P/E Normalized (Annual)32.83x
ROA (Last FY)4.78%
Revenue Growth TTM (YoY)11.75%
EBITD / Share (TTM)$5.05
ROE (5Y Avg)7.17%
Operating Margin (TTM)12.19%
Cash Flow / Share (Annual)$3.58
P/B Ratio2.66x
P/B Ratio (Quarterly)3.30x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)2.97x
Net Interest Coverage (TTM)16.01x
ROA (TTM)4.96%
EPS Growth QoQ (YoY)37.33%
EV / EBITDA (TTM)14.75x
EPS Incl Extra (Annual)$2.13
Current Ratio (Annual)4.34x
Quick Ratio (Quarterly)2.80x
3-Month Avg Trading Volume0.73M
52-Week Price Return-23.21%
EV / Free Cash Flow (Annual)21.20x
P/E Incl Extra (TTM)32.83x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$17.61
P/S Ratio (Annual)2.78x
Asset Turnover (Annual)0.56x
52-Week High$100.19
Operating Margin (5Y Avg)9.36%
EPS Excl Extra (Annual)$2.13
CapEx CAGR (5Y)11.47%
Tangible BV CAGR (5Y)12.12%
26-Week Price Return-12.14%
Quick Ratio (Annual)2.80x
13-Week Price Return-13.14%
Total Debt / Equity (Annual)0.46x
Current Ratio (Quarterly)4.34x
Enterprise Value$4,506.557
Revenue / Share Growth (5Y)7.58%
Asset Turnover (TTM)0.58x
Book Value / Share Growth (5Y)9.11%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)2.43x
Pretax Margin (Annual)11.28%
Cash / Share (Annual)$7.51
3-Month Return Std Dev26.76%
Gross Margin (5Y Avg)46.56%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)27.60%
EBITDA Interim CAGR (5Y)17.24%
ROE (Last FY)8.11%
Net Interest Coverage (Annual)16.01x
EPS Basic Excl Extra (Annual)$2.13
P/FCF (TTM)19.85x
Receivables Turnover (TTM)7.70x
EV / Free Cash Flow (TTM)21.20x
Total Debt / Equity (Quarterly)0.46x
EPS Incl Extra (TTM)$2.13
Receivables Turnover (Annual)7.70x
ROI (TTM)5.74%
P/S Ratio (TTM)2.78x
Pretax Margin (5Y Avg)8.69%
Revenue / Share (Annual)$25.07
Tangible BV / Share (Annual)$17.61
Forward P/E17.33x
Free OCF CAGR (5Y)12.87%
Price vs S&P 500 (52W)-57.85%
P/E Ratio (TTM)32.83x
EPS Growth TTM (YoY)4.76%
Year-to-Date Return-20.82%
5-Day Price Return-1.06%
EPS Normalized (Annual)$2.13
ROA (5Y Avg)4.25%
Net Profit Margin (Annual)8.48%
Month-to-Date Return1.25%
Cash Flow / Share (TTM)$3.21
EBITD / Share (Annual)$5.05
EPS Growth (3Y)18.07%
Operating Margin (Annual)12.19%
LT Debt / Equity (Annual)0.46x
P/CF (TTM)14.19x
ROI (5Y Avg)5.05%
P/E Excl Extra (TTM)32.83x
LT Debt / Equity (Quarterly)0.46x
EPS Basic Excl Extra (TTM)$2.13
P/TBV (Quarterly)4.99x
P/B Ratio (Annual)3.30x
Inventory Turnover (TTM)2.43x
Pretax Margin (TTM)11.28%
Book Value / Share (Annual)$26.66
Price vs S&P 500 (13W)-15.52%
Net Margin Growth (5Y)74.39%
Beta0.61x
P/FCF (Annual)19.85x
Revenue / Share (TTM)$25.25
ROE (TTM)8.52%
52-Week Low$66.34
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.24
4.24
4.22
4.22
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
MMSIMerit Medical Systems Inc | 2.78x | 9.48% | 48.70% | 12.19% | $69.79 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
Merit Medical Systems develops and manufactures medical devices for interventional cardiology, radiology, and endoscopy procedures. The Cardiovascular segment generates the majority of revenue, encompassing cardiology and radiology products for treating coronary artery disease, peripheral vascular disease, and other conditions, including embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.